HSCA and Amersham extend relationship
Health Services Corporation of America has extended its purchasing agreement contract with Amersham until April 30, 2006. HSCA members will continue to have access to the company’s x-ray and MRI contrast media products, as well as their
Health Services Corporation of America has extended its purchasing agreement contract with Amersham until April 30, 2006. HSCA members will continue to have access to the company’s x-ray and MRI contrast media products, as well as their brachytherapy products. Members include healthcare organizations that participate in HSCA’s Select Radiology Block. Launched in May 2000, the program was designed to reward compliance for hospitals and health systems, and to drive market share to participating suppliers.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
